Tag
Tag: Novartis
Update: The FDA Unanimously Recommends Approval of the First CAR-T Therapy
Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns
More News! Biotechs Push G20 for Support in Battle against Antibiotic Resistance
New Results from Novartis in the Race to Launch the First CAR-T
Novartis Scores Major Phase III Win with New Cardiovascular Drug
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Update: Novartis Takes on Blood Cancer with new Biosimilar Approval
Novartis Announces New Data for its Psoriasis Blockbuster Cosentyx
UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech
Novartis Gains Access to Celyad’s allogenic CAR-T cell patents
